Helperby has nearly 20 years experience designing combinations of antimicrobials in order to rejuvenate old drugs and to find more uses for drugs that already exist on the market. We have developed research tools to screen for and quantify the extent of synergy occurring between different combinations of old drugs. Using this information we can identify optimally matched combinations and most of our patented combinations see 8 to 64 fold synergy in bacterial kill counts in vitro. Synergistic interactions allow us to achieve better effects with lower doses and we have a phase II trial underway with our lead product Zidistin (improves dosing regimen of colistimethate combined with Azidothymidine). More recently Helperby Therapeutics has initiated a program aimed at a cure for the new coronavirus.
View Top Employees from Helperby TherapeuticsWebsite | http://www.helperby.com |
Revenue | $7 million |
Employees | 6 (4 on RocketReach) |
Founded | 2002 |
Address | 66 Lincoln's Inn Fields, London, England, GB |
Phone | +44 20 7084 6280 |
Technologies |
JavaScript,
HTML,
Google Analytics
+13 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Biopharma, Pharmaceuticals, Healthcare, Health Care, Science and Engineering, Life Science |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Helperby Therapeutics employee's phone or email?
The Helperby Therapeutics annual revenue was $7 million in 2024.
Anthony Coates is the Founder and Chief Scientific Officer of Helperby Therapeutics.
4 people are employed at Helperby Therapeutics.
Helperby Therapeutics is based in London, England.
The NAICS codes for Helperby Therapeutics are [5417, 54, 54171, 541714, 541].
The SIC codes for Helperby Therapeutics are [873, 87].